Tarsus Pharmaceuticals, Inc. TARS Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost?
- Tarsus Pharmaceuticals, Inc. (TARS) reported property, plant and equipment at cost of $19.97M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost increased by 300.7% year-over-year, from $4.98M to $19.97M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s property, plant and equipment at cost has grown at a 82.4% compound annual growth rate (CAGR), from $682K to $13.76M.